ESR1 and breast cancer: Schrijver et al. meta-analyzed a series of previous research on receptor mismatches in metastatic BC and showed that ER conversion occurred in 20.8% of the cases, PR conversion in 23.3%, and HER2 conversion in 12.5% during the metastasis to the central nervous system [76].